2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
EMPAG Posters<br />
most patients’ psychosocial needs. Findings highlight the benefits <strong>of</strong><br />
co-facilitation between geneticists and genetic counsellor when each<br />
has clearly defined complementary roles.<br />
EP10.23<br />
Explaining X-linked inheritance: the importance <strong>of</strong> the personal<br />
drawing<br />
T. Gale 1 , S. Pasalodos-Sanchez 2 , L. Kerzin-Storrar 1 , R. Macleod 1 ;<br />
1 Regional <strong>Genetics</strong> Service and Medical <strong>Genetics</strong> Research Group, CMMC<br />
NHS Trust and University <strong>of</strong> Manchester, Manchester, United Kingdom, 2 Nottingham<br />
Regional Clinical <strong>Genetics</strong> Service, NUH NHS Trust, Nottingham,<br />
United Kingdom.<br />
An explanation <strong>of</strong> the mechanism <strong>of</strong> inheritance is a key component <strong>of</strong><br />
many genetic consultations . However, no evidence base exists for this<br />
significant area <strong>of</strong> practice.<br />
We present the results <strong>of</strong> a process study, involving twenty-one individuals<br />
with a family history <strong>of</strong> an X-linked condition . Their genetic<br />
counselling consultations were videotaped and participants were then<br />
visited at home by the researcher . Adapting techniques <strong>of</strong> Interpersonal<br />
Process Recall, the section <strong>of</strong> videotape featuring the explanation<br />
<strong>of</strong> inheritance was played back to participants . Their responses<br />
and reflections were elicited and recorded on audiotape. In a separate<br />
arm <strong>of</strong> the study, the counsellors were shown the videotape and were<br />
similarly interviewed by a second researcher about their experience .<br />
The patients felt that a personalised diagram, drawn by the counsellor<br />
during the consultation, conveyed X-linked inheritance in a visual and<br />
engaging way, allowing them to conceptualise risk figures. Its stepwise<br />
construction facilitated slower assimilation <strong>of</strong> information, allowed<br />
room for questions and assisted with retention <strong>of</strong> the information . The<br />
diagram’s individualised nature allowed patients to contextualise their<br />
family history such that personally relevant questions could be answered<br />
. Importantly, this did not appear to require patients to first understand<br />
complicated genetic concepts such as the biological basis <strong>of</strong><br />
genes or chromosomes .<br />
Counsellors too reflected on the construction <strong>of</strong> a drawing during the<br />
consultation; which they felt helped them to both pace and individualise<br />
the explanation .<br />
This presentation will elaborate on patient and counsellor reflections<br />
on this key aspect <strong>of</strong> the genetic counselling consultation .<br />
EP10.24<br />
Explaining X-linked inheritance: the importance <strong>of</strong> the<br />
counsellor-counselee relationship<br />
S. Pasalodos-Sanchez 1 , T. Gale 2 , G. Hall 2 , L. Kerzin-Storrar 2 , R. Macleod 2 ;<br />
1 Nottingham Regional Clinical Genetic Service, NUH NHS Trust, City Campus,<br />
Nottingham, United Kingdom, 2 Regional <strong>Genetics</strong> Service and Medical <strong>Genetics</strong><br />
Research Group, CMMC NHS Trust and University <strong>of</strong> Manchester, Manchester,<br />
United Kingdom.<br />
Previous research has highlighted that the quality <strong>of</strong> the relationship<br />
between genetic counsellor and counselee can impact on a successful<br />
outcome <strong>of</strong> genetic counselling . Many studies have focused on the<br />
counselee’s perspective . We report on a process study involving 2 experienced<br />
genetic counsellors, as part <strong>of</strong> a triangulated study looking<br />
at how X-linked inheritance is explained in the genetic clinic . Following<br />
10 clinic consultations, the genetic counsellors and the researcher<br />
(SP-S) watched the relevant sections <strong>of</strong> the video together, and counsellor<br />
comments were audiotaped and transcribed .<br />
The counsellors recognised a favoured sequence for explaining Xlinked<br />
inheritance, whilst holding a goal <strong>of</strong> tailoring the explanation .<br />
This was made difficult where rapport was less well established because<br />
<strong>of</strong> lack <strong>of</strong> verbal/non-verbal cues from the patient or whether<br />
it was the first contact. Where the counsellors felt a good rapport had<br />
been achieved, they felt better able to take account <strong>of</strong> age/educational<br />
background/need for information in order to personalise the explanation<br />
more effectively .<br />
In a separate arm <strong>of</strong> the study, counselees also expressed the importance<br />
<strong>of</strong> the relationship in giving them confidence- both in themselves<br />
to ask questions for clarification- and in the counsellor’s ability to help<br />
them achieve an understanding .<br />
It is noteworthy that both counsellors and counselees reflected on<br />
counselling dynamics during the part <strong>of</strong> the consultation, which would<br />
be thought <strong>of</strong> us primarily educative .This paper will present further<br />
evidence that a division between education and counselling goals in<br />
genetic counselling consultations may be unhelpful .<br />
EP11. Strategies to facilitate decision<br />
making in genetics<br />
EP11.1<br />
the impact <strong>of</strong> a BRCA support-information group on the choice<br />
for a preventive mastectomy is limited<br />
K. M. Landsbergen;<br />
Department <strong>of</strong> <strong>Human</strong> <strong>Genetics</strong>. From the Hereditary Cancer Clinic, Nijmegen,<br />
The Netherlands.<br />
Introduction: Important aims <strong>of</strong> a BRCA group are assimilation <strong>of</strong> being<br />
BRCA1/2 carrier, and pr<strong>of</strong>essional guidance in choosing prophylactic<br />
mastectomy or breast cancer surveillance .<br />
Aim: To determine whether attending a BRCA group influences the<br />
choice for surveillance or prophylactic mastectomy .<br />
Patients and methods: 196 BRCA1/2 mutation carriers were included<br />
<strong>of</strong> who 89 participated in a BRCA group . Preference for prophylactic<br />
mastectomy was registered after mutation carriership was revealed,<br />
thus before first attendance <strong>of</strong> the group.<br />
Results: Characteristics <strong>of</strong> patients, who did or did not participate in a<br />
BRCA group, did not show any difference in demographic variables,<br />
age at breast cancer diagnosis, menopausal status or family cancer<br />
history . Preference for preventive mastectomy or surveillance was not<br />
significantly different in participators and non participators, being 31/89<br />
(35%) and 27/107 (25%) respectively (p=0 .13) .<br />
After a median observation period <strong>of</strong> 2 years (range 1-9 years) the<br />
percentage <strong>of</strong> women actually performing preventive mastectomy was<br />
significantly higher in participators than in non-participators <strong>of</strong> a BRCA<br />
group, 45% and 29% respectively (p=0 .02) . However, in the group<br />
with prior preference for mastectomy who did and did not participate<br />
in a BRCA group, prophylactic mastectomy was performed in 90%<br />
and 55%, respectively (p=0 .003), in the group with prior preference<br />
for surveillance these percentages were 19% and 20% respectively<br />
(p=0 .09) .<br />
Conclusion: The impact <strong>of</strong> a BRCA support group on the choice for<br />
prophylactic mastectomy is limited, and is determined by the woman’s<br />
preference prior to the establishment <strong>of</strong> a BRCA mutation .<br />
EP11.2<br />
Development <strong>of</strong> a tailored, online decision aid on screening<br />
options for unaffected men with a family history <strong>of</strong> prostate<br />
cancer<br />
C. Wakefield 1,2 , B. Meiser 1,2 , K. Watts 1 , A. Barratt 3 , M. Patel 3 , G. Mann 4 , E.<br />
Lobb 5,6 , K. Howard 3 , C. Gaff 7 , J. Ramsay 8 ;<br />
1 Prince <strong>of</strong> Wales Hospital, Randwick, Australia, 2 University <strong>of</strong> New South<br />
Wales, Sydney, Australia, 3 University <strong>of</strong> Sydney, Sydney, Australia, 4 University<br />
<strong>of</strong> Sydney, Westmead, Australia, 5 Curtin University <strong>of</strong> Technology, Perth, Australia,<br />
6 Edith Cowan University, Perth, Australia, 7 Genetic Health Services <strong>of</strong><br />
Victoria, Parkville, Australia, 8 Liverpool Hospital, Liverpool, Australia.<br />
PURPOSE: Men at increased risk for prostate cancer on the basis<br />
<strong>of</strong> family history are confronted with difficult decisions regarding the<br />
management <strong>of</strong> that risk . The information that needs to be conveyed<br />
is complex, and men <strong>of</strong>ten have difficulty accurately weighing up the<br />
costs and benefits <strong>of</strong> screening tests such as prostate specific antigen<br />
(PSA) screening .<br />
METHODS: This study has two stages: (i) to develop and pilot-test an<br />
online, tailored decision aid for unaffected men with a family history <strong>of</strong><br />
prostate cancer to inform them about their risk management options;<br />
and (ii) to compare in a randomised trial the efficacy <strong>of</strong> the decision<br />
aid to that <strong>of</strong> a comparison website amongst men at increased risk <strong>of</strong><br />
developing prostate cancer on the basis <strong>of</strong> family history .<br />
RESULTS: The early prototypes <strong>of</strong> the online decision aid were developed<br />
using an iterative process involving a working party comprised <strong>of</strong><br />
experts and a consumer representative . It provides information on the<br />
genetics <strong>of</strong> hereditary prostate cancer, personal and family risk <strong>of</strong> developing<br />
prostate cancer; putative protective factors; screening tests<br />
and efficacy and side-effects <strong>of</strong> treatment options. Pilot-testing with<br />
approximately 20 unaffected relatives <strong>of</strong> men diagnosed with prostate<br />
cancer is currently underway, and results will be reported from the pilot<br />
testing phase .<br />
CONCLUSION: A decision aid seems particularly suitable to provide